{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T16:05:26Z","timestamp":1726761926613},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computer Methods and Programs in Biomedicine"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.cmpb.2020.105443","type":"journal-article","created":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T03:46:42Z","timestamp":1584589602000},"page":"105443","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Reinforcement learning for optimal scheduling of Glioblastoma treatment with Temozolomide"],"prefix":"10.1016","volume":"193","author":[{"given":"Amir","family":"Ebrahimi Zade","sequence":"first","affiliation":[]},{"given":"Seyedhamidreza","family":"Shahabi Haghighi","sequence":"additional","affiliation":[]},{"given":"Madjid","family":"Soltani","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.cmpb.2020.105443_bib0001","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3322\/caac.21349","article-title":"Cancer treatment and survivorship statistics, 2016","volume":"66","author":"Miller","year":"2016","journal-title":"CA Cancer J. Clin."},{"issue":"10","key":"10.1016\/j.cmpb.2020.105443_bib0002","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1200\/JCO.2005.00.331","article-title":"Randomized phase ii study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme","volume":"23","author":"Athanassiou","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.cmpb.2020.105443_bib0003","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1088\/0031-9155\/55\/12\/001","article-title":"Predicting the efficacy of radiotherapy in individual glioblastoma patients in vivo: a mathematical modeling approach","volume":"55","author":"Rockne","year":"2010","journal-title":"Phys. Med. Biol."},{"issue":"1","key":"10.1016\/j.cmpb.2020.105443_bib0004","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/imammb\/dqr002","article-title":"Applying a patient-specific bio-mathematical model of glioma growth to develop virtual [18F]-FMISO-PET images","volume":"29","author":"Gu","year":"2012","journal-title":"Math. Med. Biol.: J. IMA"},{"issue":"23","key":"10.1016\/j.cmpb.2020.105443_bib0005","doi-asserted-by":"crossref","first-page":"9133","DOI":"10.1158\/0008-5472.CAN-08-3863","article-title":"Prognostic significance of growth kinetics in newly diagnosed glioblastomas revealed by combining serial imaging with a novel biomathematical model","volume":"69","author":"Wang","year":"2009","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.cmpb.2020.105443_bib0006","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1038\/s41598-018-20624-6","article-title":"Quantitative magnetization transfer in monitoring glioblastoma (GBM) response to therapy","volume":"8","author":"Mehrabian","year":"2018","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.cmpb.2020.105443_bib0007","doi-asserted-by":"crossref","DOI":"10.1098\/rsfs.2016.0039","article-title":"Multimodality imaging and mathematical modelling of drug delivery to glioblastomas","volume":"6","author":"Boujelben","year":"2016","journal-title":"Interface Focus"},{"issue":"26","key":"10.1016\/j.cmpb.2020.105443_bib0008","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1200\/JCO.2007.11.8554","article-title":"Chemoradiotherapy in malignant glioma: standard of care and future directions","volume":"25","author":"Stupp","year":"2007","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.cmpb.2020.105443_bib0009","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1021\/jm00368a016","article-title":"Antitumour imidazotetrazines. 1. synthesis and chemistry of 8-carbamoyl-3-(2-chloroethyl) imidazo [5, 1-d]-1, 2, 3, 5-tetrazin-4 (3H)-one, a novel broad-spectrum antitumor agent.","volume":"27","author":"Stevens","year":"1984","journal-title":"J. Med. Chem."},{"issue":"10","key":"10.1016\/j.cmpb.2020.105443_bib0010","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.cmpb.2020.105443_bib0011","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","article-title":"Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase iii study: 5-year analysis of the eortc-ncic trial","volume":"10","author":"Stupp","year":"2009","journal-title":"Lancet Oncol."},{"issue":"15","key":"10.1016\/j.cmpb.2020.105443_bib0012","doi-asserted-by":"crossref","first-page":"4738","DOI":"10.1158\/1078-0432.CCR-06-0596","article-title":"Temozolomide-Mediated radiation enhancement in glioblastoma: a report on underlying mechanisms","volume":"12","author":"Chakravarti","year":"2006","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.cmpb.2020.105443_bib0013","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1146\/annurev-pharmtox-010617-052446","article-title":"Precision medicine is not just genomics: the right dose for every patient","volume":"58","author":"Peck","year":"2018","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"25","key":"10.1016\/j.cmpb.2020.105443_bib0014","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1200\/JCO.2007.11.5964","article-title":"Correlation of O6-Methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate mgmt activity","volume":"26","author":"Hegi","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cmpb.2020.105443_bib0015","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/ncponc1155","article-title":"Mechanisms of disease: temozolomide and glioblastoma\u2014look to the future","volume":"5","author":"Mrugala","year":"2008","journal-title":"Nat. Clin. Pract. Oncol."},{"issue":"18_suppl","key":"10.1016\/j.cmpb.2020.105443_bib0016","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1200\/jco.2007.25.18_suppl.2031","article-title":"A randomized phase ii trial of concurrent temozolomide (TMZ) and radiotherapy (RT) followed by dose dense compared to metronomic tmz and maintenance CIS-retinoic acid for patients with newly diagnosed glioblastoma multiforme (GBM)","volume":"25","author":"Sul","year":"2007","journal-title":"J. Clin. Oncol."},{"issue":"18_suppl","key":"10.1016\/j.cmpb.2020.105443_bib0017","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1200\/jco.2007.25.18_suppl.2032","article-title":"One week on\/one week off regimen of Temozolomide: phase II trial in recurrent glioma","volume":"25","author":"Wick","year":"2007","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.cmpb.2020.105443_bib0018","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/sj.bjc.6603376","article-title":"Temozolomide 3 weeks on and 1 week off as first-line therapy for recurrent glioblastoma: phase ii study from gruppo italiano cooperativo di neuro-oncologia (GICNO)","volume":"95","author":"Brandes","year":"2006","journal-title":"Br. J. Cancer"},{"issue":"14","key":"10.1016\/j.cmpb.2020.105443_bib0019","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/j.ejca.2006.03.023","article-title":"Safety and pharmacokinetics of temozolomide using a dose-escalation, metronomic schedule in recurrent paediatric brain tumours","volume":"42","author":"Baruchel","year":"2006","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.cmpb.2020.105443_bib0020","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3389\/fonc.2013.00062","article-title":"From patient-specific mathematical neuro-oncology to precision medicine","volume":"3","author":"Baldock","year":"2013","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.cmpb.2020.105443_bib0021","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/sj.bjc.6600021","article-title":"Virtual brain tumours (gliomas) enhance the reality of medical imaging and highlight inadequacies of current therapy","volume":"86","author":"Swanson","year":"2002","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.cmpb.2020.105443_bib0022","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/ana.10528","article-title":"Continuous growth of mean tumor diameter in a subset of grade ii gliomas","volume":"53","author":"Mandonnet","year":"2003","journal-title":"Ann. Neurol.: Off. J. Am. Neurol. Assoc. Child Neurol. Soc."},{"issue":"3","key":"10.1016\/j.cmpb.2020.105443_bib0023","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/ana.20946","article-title":"Prognostic value of initial magnetic resonance imaging growth rates for world health organization grade ii gliomas","volume":"60","author":"Pallud","year":"2006","journal-title":"Ann. Neurol.: Off. J. Am. Neurol. Assoc. Child Neurol. Soc."},{"issue":"1","key":"10.1016\/j.cmpb.2020.105443_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/nen.0b013e31802d9000","article-title":"The evolution of mathematical modeling of glioma proliferation and invasion","volume":"66","author":"Harpold","year":"2007","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"5\u20136","key":"10.1016\/j.cmpb.2020.105443_bib0025","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.mcm.2007.02.024","article-title":"Quantifying glioma cell growth and invasion in vitro","volume":"47","author":"Swanson","year":"2008","journal-title":"Math. Comput. Model."},{"key":"10.1016\/j.cmpb.2020.105443_bib0026","series-title":"Proceedings of the International Conference on Mathematical Biology and Annual Meeting of the Society for Mathematical Biology","article-title":"Anatomic variation in quantitative measures of glioma aggressiveness","author":"Szeto","year":"2009"},{"issue":"10","key":"10.1016\/j.cmpb.2020.105443_bib0027","doi-asserted-by":"crossref","first-page":"4502","DOI":"10.1158\/0008-5472.CAN-08-3884","article-title":"Quantitative metrics of net proliferation and invasion link biological aggressiveness assessed by mri with hypoxia assessed by fmiso-pet in newly diagnosed glioblastomas","volume":"69","author":"Szeto","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.cmpb.2020.105443_bib0028","series-title":"Neuro-oncology","article-title":"Pre-treatment glioblastoma proliferation and invation kinetics: a mechanism to predict pseudoprogression","author":"Boone","year":"2010"},{"issue":"1","key":"10.1016\/j.cmpb.2020.105443_bib0029","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/imammb\/dqr002","article-title":"Applying a patient-specific bio-mathematical model of glioma growth to develop virtual [18F]-FMISO-PET images","volume":"29","author":"Gu","year":"2012","journal-title":"Math. Med. Biol.: J. IMA"},{"issue":"4","key":"10.1016\/j.cmpb.2020.105443_bib0030","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.clon.2008.01.006","article-title":"Velocity of radial expansion of contrast-enhancing gliomas and the effectiveness of radiotherapy in individual patients: a proof of principle","volume":"20","author":"Swanson","year":"2008","journal-title":"Clin. Oncol."},{"issue":"4","key":"10.1016\/j.cmpb.2020.105443_bib0031","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1023\/A:1022644031905","article-title":"Quantifying efficacy of chemotherapy of brain tumors with homogeneous and heterogeneous drug delivery","volume":"50","author":"Swanson","year":"2002","journal-title":"Acta Biotheor."},{"issue":"1","key":"10.1016\/j.cmpb.2020.105443_bib0032","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/sj.bjc.6604125","article-title":"A mathematical modelling tool for predicting survival of individual patients following resection of glioblastoma: a proof of principle","volume":"98","author":"Swanson","year":"2008","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.cmpb.2020.105443_bib0033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2003.06.001","article-title":"Virtual and real brain tumors: using mathematical modeling to quantify glioma growth and invasion","volume":"216","author":"Swanson","year":"2003","journal-title":"J. Neurol. Sci."},{"issue":"8","key":"10.1016\/j.cmpb.2020.105443_bib0034","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1109\/TBME.2006.873761","article-title":"A spatiotemporal, patient individualized simulation model of solid tumor response to chemotherapy in vivo: the paradigm of glioblastoma multiforme treated by temozolomide","volume":"53","author":"Stamatakos","year":"2006","journal-title":"IEEE Trans. Biomed. Eng."},{"issue":"11","key":"10.1016\/j.cmpb.2020.105443_bib0035","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1088\/0031-9155\/52\/11\/023","article-title":"Mathematical modeling of brain tumors: effects of radiotherapy and chemotherapy","volume":"52","author":"Powathil","year":"2007","journal-title":"Phys. Med. Biol."},{"issue":"3","key":"10.1016\/j.cmpb.2020.105443_bib0036","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jtbi.2009.10.021","article-title":"A mathematical model of brain tumour response to radiotherapy and chemotherapy considering radiobiological aspects","volume":"262","author":"Barazzuol","year":"2010","journal-title":"J. Theor. Biol."},{"issue":"1","key":"10.1016\/j.cmpb.2020.105443_bib0037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-4827(02)00027-7","article-title":"Necrosis: a specific form of programmed cell death?","volume":"283","author":"Proskuryakov","year":"2003","journal-title":"Exp. Cell Res."},{"issue":"8","key":"10.1016\/j.cmpb.2020.105443_bib0038","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183810","article-title":"Hybrid multiscale modeling and prediction of cancer cell behavior","volume":"12","author":"Zangooei","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.cmpb.2020.105443_bib0039","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cmpb.2016.08.011","article-title":"Integrating evolutionary game theory into an agent-based model of ductal carcinoma in situ: role of gap junctions in cancer progression","volume":"136","author":"Malekian","year":"2016","journal-title":"Comput. Methods Programs Biomed."},{"issue":"3","key":"10.1016\/j.cmpb.2020.105443_bib0040","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2214\/ajr.162.3.8109501","article-title":"Ductal carcinoma in situ: the mammographer's perspective","volume":"162","author":"Stomper","year":"1994","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.cmpb.2020.105443_bib0041","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jtbi.2012.02.002","article-title":"Patient-calibrated agent-based modelling of ductal carcinoma in situ (DCIS): from microscopic measurements to macroscopic predictions of clinical progression","volume":"301","author":"Macklin","year":"2012","journal-title":"J. Theor. Biol."},{"issue":"8","key":"10.1016\/j.cmpb.2020.105443_bib0042","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1093\/bioinformatics\/btv730","article-title":"BioFVM: an efficient, parallelized diffusive transport solver for 3-D biological simulations","volume":"32","author":"Ghaffarizadeh","year":"2016","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.cmpb.2020.105443_bib0043","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0305-7372(97)90019-0","article-title":"Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials","volume":"23","author":"Newlands","year":"1997","journal-title":"Cancer Treat. Rev."},{"issue":"2","key":"10.1016\/j.cmpb.2020.105443_bib0044","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1634\/theoncologist.5-2-144","article-title":"Temozolomide, a novel alkylating agent with activity in the central nervous system, may improve the treatment of advanced metastatic melanoma","volume":"5","author":"Agarwala","year":"2000","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.cmpb.2020.105443_bib0045","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2165\/00024669-200201010-00006","article-title":"Temozolomide","volume":"1","author":"Darkes","year":"2002","journal-title":"Am. J. Cancer"},{"issue":"9","key":"10.1016\/j.cmpb.2020.105443_bib0046","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S1470-2045(01)00489-2","article-title":"Current and future developments in the use of temozolomide for the treatment of brain tumours","volume":"2","author":"Stupp","year":"2001","journal-title":"Lancet Oncol."},{"issue":"4","key":"10.1016\/j.cmpb.2020.105443_bib0047","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/jps.2600610408","article-title":"General treatment of linear mammillary models with elimination from any compartment as used in pharmacokinetics","volume":"61","author":"Benet","year":"1972","journal-title":"J. Pharm. Sci."},{"issue":"10","key":"10.1016\/j.cmpb.2020.105443_bib0048","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1023\/A:1026403805756","article-title":"Population pharmacokinetics of temozolomide in cancer patients","volume":"17","author":"Jen","year":"2000","journal-title":"Pharm. Res."},{"key":"10.1016\/j.cmpb.2020.105443_bib0049","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/bjc.1980.165","article-title":"Dependence of the cytostatic effect of adriamycin on drug concentration and exposure time in vitro","volume":"41","author":"Eichholtz-Wirth","year":"1980","journal-title":"Br. J. Cancer"},{"year":"1998","series-title":"Reinforcement Learning: An Introduction","author":"Sutton","key":"10.1016\/j.cmpb.2020.105443_bib0050"},{"issue":"12","key":"10.1016\/j.cmpb.2020.105443_bib0051","doi-asserted-by":"crossref","first-page":"10037","DOI":"10.1109\/TVT.2016.2524258","article-title":"PHY-Layer spoofing detection with reinforcement learning in wireless networks","volume":"65","author":"Xiao","year":"2016","journal-title":"IEEE Trans. Veh. Technol."},{"year":"1989","series-title":"Learning from Delayed Rewards","author":"Watkins","key":"10.1016\/j.cmpb.2020.105443_bib0052"},{"issue":"1","key":"10.1016\/j.cmpb.2020.105443_bib0053","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10994-010-5229-0","article-title":"Informing sequential clinical decision-making through reinforcement learning: an empirical study","volume":"84","author":"Shortreed","year":"2011","journal-title":"Mach. Learn."},{"issue":"26","key":"10.1016\/j.cmpb.2020.105443_bib0054","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1002\/sim.3720","article-title":"Reinforcement learning design for cancer clinical trials","volume":"28","author":"Zhao","year":"2009","journal-title":"Stat. Med."},{"issue":"4","key":"10.1016\/j.cmpb.2020.105443_bib0056","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1111\/j.1541-0420.2011.01572.x","article-title":"Reinforcement learning strategies for clinical trials in nonsmall cell lung cancer","volume":"67","author":"Zhao","year":"2011","journal-title":"Biometrics"},{"key":"10.1016\/j.cmpb.2020.105443_bib0057","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.matcom.2016.05.008","article-title":"Simulation-based optimization of radiotherapy: agent-based modeling and reinforcement learning","volume":"133","author":"Jalalimanesh","year":"2017","journal-title":"Math. Comput. Simul."},{"key":"10.1016\/j.cmpb.2020.105443_bib0058","first-page":"1","article-title":"Multi-objective optimization of radiotherapy: distributed Q-learning and agent-based simulation","author":"Jalalimanesh","year":"2017","journal-title":"J. Exp. Theor. Artif. Intell."},{"year":"2007","series-title":"Mathematical Biology: I. An Introduction (Interdisciplinary Applied Mathematics)","author":"Murray","key":"10.1016\/j.cmpb.2020.105443_bib0059"},{"issue":"5","key":"10.1016\/j.cmpb.2020.105443_bib0060","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1046\/j.1365-2184.2000.00177.x","article-title":"A quantitative model for differential motility of gliomas in grey and white matter","volume":"33","author":"Swanson","year":"2000","journal-title":"Cell Prolif."},{"key":"10.1016\/j.cmpb.2020.105443_bib0061","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jtbi.2012.05.015","article-title":"Modelling the effects of cell-cycle heterogeneity on the response of a solid tumour to chemotherapy: biological insights from a hybrid multiscale cellular automaton model","volume":"308","author":"Powathil","year":"2012","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.cmpb.2020.105443_bib0062","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtbi.2006.06.034","article-title":"Development of a three-dimensional multiscale agent-based tumor model: simulating gene-protein interaction profiles, cell phenotypes and multicellular patterns in brain cancer","volume":"244","author":"Zhang","year":"2007","journal-title":"J. Theor. Biol.,"},{"key":"10.1016\/j.cmpb.2020.105443_bib0063","first-page":"210","article-title":"Neoplasms affecting the nervous system of the elderly","author":"Alvord","year":"1991","journal-title":"Pathol. Aging Hum. Nerv. Syst."},{"issue":"21","key":"10.1016\/j.cmpb.2020.105443_bib0064","doi-asserted-by":"crossref","first-page":"R344","DOI":"10.1088\/0031-9155\/61\/21\/R344","article-title":"Methodologies in the modeling of combined chemo-radiation treatments","volume":"61","author":"Grassberger","year":"2016","journal-title":"Phys. Med. Biol."},{"issue":"8","key":"10.1016\/j.cmpb.2020.105443_bib0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1003800","article-title":"Classical mathematical models for description and prediction of experimental tumor growth","volume":"10","author":"Benzekry","year":"2014","journal-title":"PLoS Comput. Biol."},{"issue":"8","key":"10.1016\/j.cmpb.2020.105443_bib0066","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1158\/0008-5472.CAN-12-4355","article-title":"The model muddle: in search of tumor growth laws","volume":"73","author":"Gerlee","year":"2013","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.cmpb.2020.105443_bib0067","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3171\/jns.1985.63.3.0426","article-title":"Stem cell studies of human malignant brain tumors: part 2: proliferation kinetics of brain-tumor cells in vitro in early-passage cultures","volume":"63","author":"Pertuiset","year":"1985","journal-title":"J. Neurosurg."},{"issue":"6","key":"10.1016\/j.cmpb.2020.105443_bib0068","first-page":"354","article-title":"Computer simulation and modelling of tumor spheroid growth and their relevance for optimization of fractionated radiotherapy","volume":"168","author":"Duechting","year":"1992","journal-title":"Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft...[et al.]"},{"year":"2012","series-title":"Basic and Clinical Pharmacology (lange basic Science)","author":"Katzung","key":"10.1016\/j.cmpb.2020.105443_bib0069"},{"key":"10.1016\/j.cmpb.2020.105443_bib0070","series-title":"Multiscale Computer Modeling in Biomechanics and Biomedical Engineering","first-page":"349","article-title":"Modeling multiscale necrotic and calcified tissue biomechanics in cancer patients: application to ductal carcinoma in situ (DCIS)","author":"Macklin","year":"2013"},{"issue":"5","key":"10.1016\/j.cmpb.2020.105443_bib0071","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1046\/j.1365-2184.2000.00177.x","article-title":"A quantitative model for differential motility of gliomas in grey and white matter","volume":"33","author":"Swanson","year":"2000","journal-title":"Cell Prolif."},{"issue":"6","key":"10.1016\/j.cmpb.2020.105443_bib0072","first-page":"241","article-title":"O6-Alkylguanine DNA-alkyltransferase is not a major determinant of sensitivity to 1,3-Bis(2-chloroethyl)-1-nitrosourea in four medulloblastoma cell lines","volume":"4","author":"Silber","year":"1992","journal-title":"Oncol. Res. Incorp. Anti-Cancer Drug Design"},{"issue":"4","key":"10.1016\/j.cmpb.2020.105443_bib0073","first-page":"735","article-title":"Role of O6-methylguanine-DNA methyltransferase in resistance of human brain tumor cell lines to the clinically relevant methylating agents temozolomide and streptozotocin","volume":"2","author":"Bobola","year":"1996","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.cmpb.2020.105443_bib0074","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/mc.2940130204","article-title":"Contribution of O6-methylguanine-DNA methyltransferase to resistance to 1,3-(2-chloroethyl)-1-nitrosourea in human brain tumor-derived cell lines","volume":"13","author":"Bobola","year":"1995","journal-title":"Mol. Carcinog."},{"issue":"4","key":"10.1016\/j.cmpb.2020.105443_bib0075","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1365-2184.2009.00613.x","article-title":"Virtual glioblastoma: growth, migration and treatment in a three-dimensional mathematical model","volume":"42","author":"Eikenberry","year":"2009","journal-title":"Cell Prolif."},{"key":"10.1016\/j.cmpb.2020.105443_bib0076","series-title":"Scientific Modeling and Simulations","first-page":"381","article-title":"Computational modeling of brain tumors: discrete, continuum or hybrid?","author":"Wang","year":"2008"},{"issue":"10","key":"10.1016\/j.cmpb.2020.105443_bib0078","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1586\/14737140.6.10.1361","article-title":"Mathematical modeling of cancer progression and response to chemotherapy","volume":"6","author":"Sanga","year":"2006","journal-title":"Expert Rev. Anticancer Ther."},{"year":"2011","series-title":"Approximate Dynamic Programming, Solving the Curses of Dimensionality","author":"Powell","key":"10.1016\/j.cmpb.2020.105443_bib0079"},{"key":"10.1016\/j.cmpb.2020.105443_bib0080","series-title":"Optimization and Neural Computation Series","article-title":"Neuro-Dynamic programming","author":"Bertsekas","year":"1996"}],"container-title":["Computer Methods and Programs in Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169260719316013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169260719316013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T23:13:44Z","timestamp":1594336424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169260719316013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":78,"alternative-id":["S0169260719316013"],"URL":"https:\/\/doi.org\/10.1016\/j.cmpb.2020.105443","relation":{},"ISSN":["0169-2607"],"issn-type":[{"type":"print","value":"0169-2607"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reinforcement learning for optimal scheduling of Glioblastoma treatment with Temozolomide","name":"articletitle","label":"Article Title"},{"value":"Computer Methods and Programs in Biomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmpb.2020.105443","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105443"}}